92 related articles for article (PubMed ID: 33015156)
21. Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma.
Xu J; Zou J; Wu L; Lu W
Sci Rep; 2020 Oct; 10(1):16584. PubMed ID: 33024199
[TBL] [Abstract][Full Text] [Related]
22. Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
Li Y; Wang H; Zhang Y; Jing X; Wu N; Hou Y; Hao C
Int J Gynaecol Obstet; 2021 Jan; 152(1):96-102. PubMed ID: 33020921
[TBL] [Abstract][Full Text] [Related]
23. Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high-risk human papillomavirus cervical carcinomas.
Liu JJ; Ho JY; Lee JE; Hur SY; Yoo J; Kim KR; Ryu D; Kim TM; Choi YJ
Cancer Med; 2020 Nov; 9(21):8243-8257. PubMed ID: 33017516
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA Levels in Cervical Cancer Samples and Relationship with Lesion Grade and HPV Infection.
Hoelzle CR; Arnoult S; Borém CRM; Ottone M; de Magalhães KCSF; da Silva IL; Simões RT
Microrna; 2021; 10(2):139-145. PubMed ID: 34086555
[TBL] [Abstract][Full Text] [Related]
25. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
26. NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs.
Kniazeva M; Zabegina L; Shalaev A; Smirnova O; Lavrinovich O; Berlev I; Malek A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298066
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic Viruses-Encoded microRNAs and Their Role in the Progression of Cancer: Emerging Targets for Antiviral and Anticancer Therapies.
Kandeel M
Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111242
[TBL] [Abstract][Full Text] [Related]
28. miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy.
Wang W; Liu L; Tian Y
Genet Res (Camb); 2023; 2023():4784500. PubMed ID: 36908850
[TBL] [Abstract][Full Text] [Related]
29. The Epidemiological Characteristics of Noncommunicable Diseases and Malignant Tumors in Guiyang, China: Cross-sectional Study.
Zeng Q; Yang J; Wang Z; Liu H; Wang J; Yang T; Hu J; Guan H; Lu Y; Liu H; Hong F
JMIR Public Health Surveill; 2022 Oct; 8(10):e36523. PubMed ID: 36306160
[TBL] [Abstract][Full Text] [Related]
30. Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.
Gebrie A
PLoS One; 2022; 17(7):e0268480. PubMed ID: 35895593
[TBL] [Abstract][Full Text] [Related]
31. The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs.
Chiantore MV; Iuliano M; Mongiovì RM; Dutta S; Tommasino M; Di Bonito P; Accardi L; Mangino G; Romeo G
Infect Agent Cancer; 2022 Jun; 17(1):29. PubMed ID: 35705991
[TBL] [Abstract][Full Text] [Related]
32. Cervical Cancer, Papillomavirus, and miRNA Dysfunction.
Bañuelos-Villegas EG; Pérez-yPérez MF; Alvarez-Salas LM
Front Mol Biosci; 2021; 8():758337. PubMed ID: 34957212
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis.
Wang H; Xu J; Ding L
Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469
[TBL] [Abstract][Full Text] [Related]
34. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
[TBL] [Abstract][Full Text] [Related]
35. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
36. Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells.
Zhang S; Liu F; Mao X; Huang J; Yang J; Yin X; Wu L; Zheng L; Wang Q
Int J Oncol; 2015 Nov; 47(5):1759-66. PubMed ID: 26397063
[TBL] [Abstract][Full Text] [Related]
37. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
38. The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.
Choi PW; Liu TL; Wong CW; Liu SK; Lum YL; Ming WK
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806128
[TBL] [Abstract][Full Text] [Related]
39. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
